logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Dario C Altieri

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignee: Scripps Research Institute. Active years: 1995-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dario C Altieri. Retrieved from https://idiyas.com/inventor/dario-c-altieri-yqa2o9y3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal8 out of 1,208 
 
Scripps Research Institute
 patents

Years Active: 1995-2004

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6737058 - Methods for inhibiting endothelial cell and fibrinogen mediated inflammation using fibrinogen specific antibodies (2004-05-18),
2. 6676940 - Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation (2004-01-13),
3. 6265549 - Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation (2001-07-24),
4. 6238875 - Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1 (2001-05-29),
5. 6072028 - EPR-1 proteins, polypeptides, and nucleic acid molecules encoding same (2000-06-06),
6. 5919754 - Method of inhibiting fibrinogen binding to endothelial cells with (1999-07-06),
7. 5599790 - Fibrinogen .gamma. chain polypeptide and compositions thereof (1997-02-04),
8. 5473051 - Inhibition of Mac-1 receptor binding to fibrinogen using D.sub.30 (1995-12-05),

Title: Dario C. Altieri: Innovator in Therapeutic Compositions

Introduction

Dario C. Altieri is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of therapeutic compositions, particularly in the context of inflammation. With a total of 8 patents to his name, Altieri's work has the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, Altieri has developed methods for inhibiting endothelial cell and fibrinogen-mediated inflammation using fibrinogen-specific antibodies. This invention includes therapeutic compositions that contain a fibrinogen homolog capable of binding to endothelial cells in an RGD-independent manner, effectively inhibiting fibrinogen binding to these cells. Additionally, he has described therapeutic compositions containing an ICAM-1 homolog that also binds to fibrinogen in an RGD-independent manner, further contributing to the inhibition of inflammation.

Career Highlights

Dario C. Altieri is affiliated with The Scripps Research Institute, where he conducts his research and development. His innovative approaches to therapeutic compositions have garnered attention in the scientific community, showcasing his dedication to advancing medical science.

Collaborations

Altieri has collaborated with notable colleagues, including Lucia R. Languino and George B. Thornton. These partnerships have likely enriched his research and contributed to the success of his inventions.

Conclusion

Dario C. Altieri stands out as a key figure in the development of therapeutic compositions aimed at combating inflammation. His innovative patents and collaborations reflect his commitment to improving medical treatments and advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…